BRCT repeats as phosphopeptide-binding modules involved in protein targeting

Area of Science:

• Molecular Biology
• Cellular Signaling
• Cancer Research

Background:

• The DNA damage response (DDR) is crucial for maintaining genomic stability.
• Signal transduction pathways involving protein phosphorylation play a vital role in the DDR.
• Identifying specific molecular interactions is key to understanding DDR mechanisms.

Purpose of the Study:

• To identify phosphopeptide-binding modules involved in DDR signal transduction.
• To elucidate the role of these modules in recognizing phosphorylated substrates.
• To understand the functional consequences of these interactions in DNA repair.

Main Methods:

• Proteomic approach utilizing a library of partially degenerate phosphopeptides.
• Identification and characterization of protein domains responsible for phosphopeptide binding.
• Analysis of protein localization in response to DNA damage (gamma-irradiation).

Main Results:

• Tandem BRCT (BRCA1 carboxyl-terminal) domains in PTIP (Pax transactivation domain-interacting protein) and BRCA1 were identified as specific binding modules.
• These BRCT domains recognize phosphoserine or phosphothreonine residues on substrates phosphorylated by ATM (ataxia telangiectasia-mutated) and ATR (ataxia telangiectasia- and RAD3-related) kinases.
• PTIP tandem BRCT domains mediate phosphorylation-dependent localization to nuclear foci containing 53BP1 and gamma-H2AX, a marker of DNA damage.

Conclusions:

• The study provides a molecular basis for the function of BRCT domains in the DNA damage response.
• BRCT domains act as critical phosphopeptide-binding modules in DDR signaling.
• Understanding BRCT domain function and mutations, like BRCA1 Met1775Arg, can explain predisposition to breast and ovarian cancer.